Sign in

or Register now

CholesterolNetwork.com

See all of our health sites at www.HealthCentral.com
Saturday, September, 06, 2008

All SharePosts Relating To "Journal Entry"

EXPERT
Dr. Kang

Dr. Kang

(Profile)
Cardiologist
posted 12/13/2007, comments (0)

Is there life for CETP inhibitors after the death of torcetrapib?

In the beginning of this year, I wrote two articles concerning torcetrapib, the $800 million failure of Pfizer to develop a new type of cholesterol medication. This novel medication called a CETP (cholesterol ester transfer protein) inhibitor is able to markedly raise HDL, but unfortunately was found to increase the risk of death. The... Read moreChevron
EXPERT
Dr. William Davis

Dr. William Davis

(Profile)
Heart Disease Specialist
posted 11/06/2007, comments (0)

Was Torcetrapib’s Crash and Burn Fatal for this Class of Drug?

Dr. Philip Barter of the Heart Research Institute of Sydney, Australia, presented an update of the disappointing ILLUMINATE clinical drug trial for the once-promising drug, torcetrapib, at the 2007 American Heart Association meetings in Orlando, Florida.   The crash and burn of drug manufacturer Pfizer's torcetrapib in December 2006... Read moreChevron
howard58
posted 11/06/2007, comments (0)

howard58

Walked 11405 steps2.15 miles125 calories
EXPERT
Dr. Kang

Dr. Kang

(Profile)
Cardiologist
posted 10/01/2007, comments (0)

Cholesterol Education Month: A Year in Review and What’s to Come

Now that National Cholesterol Education Month has ended, I thought this would be a good time to highlight some of the recent accomplishments in cholesterol treatment during this past year. But it's only fair to also highlight some of our recent failures as well. Looking at both our successes and failures helps us to gain a perspective on... Read moreChevron
EXPERT
Dr. Kang

Dr. Kang

(Profile)
Cardiologist
posted 09/20/2007, comments (0)

Knowing your heart disease risk: How does cholesterol fit in?

It's quite commonly known that high total cholesterol and LDL levels are directly related to an increased risk of heart disease and that the relationship is graded and continuous. This risk even applies to people under the age of 40. Low HDL and high triglycerides also contribute to this risk but apparently to a lesser extent, especially... Read moreChevron

Ask a Question

Get answers from our experts and community members.

Answer a Question

My mother is elderly and she is taking both zocor and tricor. Is this ok?

Answer This View all questions >
Free Newsletter
Get weekly updates, news alerts and more on Cholesterol and related health conditions.